Hi ,
Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.
% completed
%
1 This profile is validated by 1 label.
Company
VIROSTATICS srl
14
EQ SCORE The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.
Privately held small pharmaceutical company dedicated to the discovery and the development of novel compounds for the treatment of cancers and viral diseases. Validated assays to test antivirals against COVID-19 offered by a highly qualified team.
Sassari, Sardinia, Italy
Send a message
- 9
employees
English
VIROSTATICS srl
English
ViroStatics is a privately held small pharmaceutical company dedicated to the discovery and the development of novel compounds for a multifaceted treatment of cancers and viral diseases, focusing on novel, selective, host cell kinase targeted inhibitors.
The Company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy and safety profiles.
Consistent with its...
ViroStatics is a privately held small pharmaceutical company dedicated to the discovery and the development of novel compounds for a multifaceted treatment of cancers and viral diseases, focusing on novel, selective, host cell kinase targeted inhibitors.
The Company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy and safety profiles.
Consistent with its well defined mechanism of action, ViroStatics’ lead compound has a good toxicity profile while exerting potent activity in preclinical models against most aggressive cancers with high unmet need such as lung cancer, pancreatic cancer, highly malignant lymphoma and acute leukemia.
The Team and Advisors combines scientific, business, legal, and technology expertise, spanning the entire process of drug development from translational science through preclinical and clinical drug development.
ViroStatics has been awarded with H2020 Seal of Excellence and subsequently obtained funding under the Horizon 2020’s SME Instrument Phase 1 Call H2020-SME Inst-2016-2017 in the area of Dedicated Support to Biotechnology.
Team member(s)
Your request has been sent
Board member(s)
Employee(s)
Join this organization
Your request has been sent
Team member(s)
Board member(s)
Employee(s)
Our network
Your request has been sent
Join this network
Your message has been sent
Certifications
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1278 Entities
Communities
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
https://access2eic.eu/
1789 Members
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
1150 Members